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Abstract
A 63-year-old woman was admitted to our hospital with a right lower abdominal mass and general fatigue.
Preoperative examination suggested a large ovarian tumor or cecal carcinoma. However, her intraoperative
diagnosis was colon cancer; we therefore performed an ileocecal resection with oophorectomy. The tumor was
pathologically diagnosed as adenosquamous carcinoma T4bN1M-stage IIIa. We administrated CapeOX adjuvant
chemotherapy for 6 months. Adenosquamous carcinoma is extremely rare, at around 0.1% of all colorectal cancers,
and usually has a poor prognosis. The patient is still alive without recurrence after 84 post-operative months, even
with later developments of metachronous early colorectal cancer and breast cancer. We herein report a rare case of
cecal ASC with good prognosis.
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Introduction
More than 90% of colorectal cancer (CRC) is well-to-
moderately differentiated adenocarcinoma. Primary adeno-
squamous carcinoma (ASC) of the colon is extremely rare. It has
high malignant potential and its long-term prognosis is usually
unfavorable.1 Here, we report a rare case of cecal ASC with good
prognosis.
Case report
A 63-year-old woman was admitted to our hospital with a right
lower abdominal mass. She had no relevant previous medical or
family history. On admission, her height and body weight were
145 cm and 40 kg, respectively. Her initial laboratory data
showed severe anemia, with hemoglobin levels of 5.6 g/dL, red
blood cell count of 3.888×106/μL, and platelet count of 69.4×104/
μL, as well as slight transaminitis and proteinemia. Marker
antigen levels were carcinoembryonic antigen (CEA): 1.9 ng
(normal: <5.0); carbohydrate antigen 19-9 (CA19-9): 0.1 U/mL
(normal: <37); and squamous cell carcinoma (SCC) antigen:
0.6 ng/mL (normal: <1.5).
Abdominopelvic contrast-enhanced computed tomography
(CT) showed a large mass involving the cecum and the right
ovary, with well-contrasted circumference vessels. The tumor
size was 100×80×70 mm, and was of suspected cecal origin,
with swelling of the mesenteric lymph nodes (Figure 1). Barium
enema findings showed cecal wall thickness and obstruction with
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a “apple core sign”; however, barium flow to the ileum was good
(Figure 2).
Colonoscopy and biopsy could not be performed as the patient
refused; therefore, histological diagnosis was not possible.
Surgery was performed with a pre-operative diagnosis of
carcinoma with the suspected origin in cecum or right ovary.
During surgery, we identified the origin of this tumor as a cecal
carcinoma, with invasion to the retroperitoneum and right ovary,
as well as the right external iliac artery. We performed an
ileocecal resection with bilateral oophorectomy, partial resection
of iliopsoas muscle, and D3 lymph node resection. We observed
no evidence of peritoneum dissemination or hepatic metastases.
Figure 1 Abdominopelvic contrast-enhanced computed tomography
shows a large mass of the cecum and right ovary with well-contrasted
circumference vessels.
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Pathological findings showed a type 2 tumor, measuring 10 cm
in diameter at the cecum, that had invaded to the right ovary and
iliopsoas muscle. The tumor was pathologically diagnosed as
adenosquamous cell carcinoma, T4b (retroperitoneum), int, INFβ,
ly2, v1, n1(2/11), 2RAS-wild type. Immunohistochemical exami-
nation showed it to be MLH1+, PMS2+, and MSH6+ (Figures
3, 4).
The patient had no postoperative complications. She received
eight courses of adjuvant chemotherapy with CapeOX
(capecitabine 2000 mg/m2 PO d1–14, oxaliplatin 130 mg/m2 civ
d1) over 6 months. A colonoscopy performed 18 months after the
Figure 2 Cecum wall thickness and obstruction showing severe “apple
core sign.”
initial surgery found an Isp polyp at the sigmoid colon, for which
an endoscopic mucosal resection was performed. Pathological
findings of the polyp revealed a well-differentiated adeno-
carcinoma, depth 500 μm, ly0, v0. A follow-up CT 7 years after
the initial surgery revealed a tumor of the right breast, diagnosed
as invasive ductal carcinoma, and resected. The patient is
currently receiving postoperative adjuvant hormonal therapy and
is alive 8 years after the first surgery, with no recurrence of
colonic ASC.
Discussion
Japanese clinical guidelines for colon cancer define ASC of the
colon as a neoplasm that comprises adenocarcinoma and SCC.
The histogenesis of ASC of the colon is not clearly understood,
Figure 3 Ileocecum specimen shows type 2 cancer in the cecum.
Figure 4 Microscopic and immunohistochemical features of adenosquamous carcinoma of the cecum. (a) Histological findings. Blue: adenocarcinoma
(AD) component; red: squamous cell carcinoma (SCC) component (hematoxylin and eosin [H&E]; loupe). (b) Ductal and cribriform pattern of atypical
columnar AD cells (H&E; 200× magnification). (c) Island pattern by dysplastic squamous epithelium with keratinization in SCC component (H&E; 200×
magnification). Immunohistochemistry shows SCC component is (d) strongly 34βE12+, (e) p40+, and (f) focally positive for carcinoembryonic antigen
( 200× magnification for each).
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but three hypotheses have been suggested: (1) undifferentiated
or reverse cells in the colonic epithelium may change directly
into SCC; (2) secondary ASC derived from adenocarcinoma
(currently, the most widely accepted explanation); and (3) ectopic
squamous cells in the colonic mucosa may be directly
transformed into squamous malignant cells.3,4 ASC of the colon is
rare, with an incidence of 0.1%−0.2% among all CRCs.5 Masoomi
et al. reported a population-based evaluation of ASC of the colon
in the California Cancer Registry from 1994 to 2004; they found
that out of 111,263 cases of CRC, ASC was identified in only 99
cases (0.09%).6 The most common location was the proximal
colon and the median age was 67 years, which is similar to our
present case. As colorectal ASC tends to form both regional and
distant metastases, its long-term prognosis is often unfavorable,
with an overall 5-year survival rate of only 31%. A study of 576
patients with ASC in Taiwan showed 27 had colorectal ASC
(0.04%); it found that colorectal ASC was most likely to affect the
respiratory system (73.8%), followed by the alimentary canal
(16.2%), and the female reproductive tract (10%), and that
prognosis for ASC of the colon was much worse than for other
primary ASCs.7,8 Data from the National Institutes of Health also
showed a poor prognosis, which Hijikawa et al. suggested was
due to the very rapid growth of secondary ASC derived from
adenocarcinoma.4 Our present patient had no distant metastases,
but as she had lymph node metastases and T4b tumor depth, she
had a high risk of recurrence. She received adjuvant
chemotherapy using CapeOX for colon adenocarcinoma; however,
the exact role of adjuvant chemotherapy remains unclear.9
In the present case, the patient developed early sigmoid colon
cancer at 1 year after the first surgery and advanced breast
cancer at 7 years after. Metachronous colon cancer is a criterion
for Lynch syndrome in the Revised Bethesda guidelines.
Raymond et al. reported the possibility of Lynch syndrome-
associated breast and prostate cancers.10 In the present case, the
specimen was immunopositive for MLH1, PMS2, and MSH6;
however, these proteins are not clearly described in the criteria
and we conclude this case is not Lynch syndrome. Recently,
Duncan et al. reported high microsatellite instability in ASC and
ASC with Lynch syndrome.11–13
As no biomarkers for diagnosis and prognosis are currently
known, we should treat ASC as conventional adenocarcinoma. In
the future, we expect genetic analysis using next-generation
sequencing to assist in drug and treatment choice. Erik et al.
reported molecular profiling of lung ASC.14 Because of the rarity
of colonic ASC, countrywide registry database systems and gene
analysis programs are required.
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